In vitro drug susceptibility of Mycobacterium bovis BCG Connaught and Tokyo strains. 2010

Toshiaki Shimizu, and Ko Yasumoto, and Yutaka Tatano, and Haruaki Tomioka, and Katsumasa Sato, and Chiaki Sano, and Hiromi Kumon, and Koichi Monden

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009163 Mycobacterium bovis The bovine variety of the tubercle bacillus. It is called also Mycobacterium tuberculosis var. bovis. BCG,Calmette-Guerin Bacillus
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

Toshiaki Shimizu, and Ko Yasumoto, and Yutaka Tatano, and Haruaki Tomioka, and Katsumasa Sato, and Chiaki Sano, and Hiromi Kumon, and Koichi Monden
December 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
Toshiaki Shimizu, and Ko Yasumoto, and Yutaka Tatano, and Haruaki Tomioka, and Katsumasa Sato, and Chiaki Sano, and Hiromi Kumon, and Koichi Monden
January 2009, Antimicrobial agents and chemotherapy,
Toshiaki Shimizu, and Ko Yasumoto, and Yutaka Tatano, and Haruaki Tomioka, and Katsumasa Sato, and Chiaki Sano, and Hiromi Kumon, and Koichi Monden
October 1990, Canadian journal of microbiology,
Toshiaki Shimizu, and Ko Yasumoto, and Yutaka Tatano, and Haruaki Tomioka, and Katsumasa Sato, and Chiaki Sano, and Hiromi Kumon, and Koichi Monden
January 2003, Journal of basic microbiology,
Toshiaki Shimizu, and Ko Yasumoto, and Yutaka Tatano, and Haruaki Tomioka, and Katsumasa Sato, and Chiaki Sano, and Hiromi Kumon, and Koichi Monden
January 1997, Cytobios,
Toshiaki Shimizu, and Ko Yasumoto, and Yutaka Tatano, and Haruaki Tomioka, and Katsumasa Sato, and Chiaki Sano, and Hiromi Kumon, and Koichi Monden
March 2021, mSphere,
Toshiaki Shimizu, and Ko Yasumoto, and Yutaka Tatano, and Haruaki Tomioka, and Katsumasa Sato, and Chiaki Sano, and Hiromi Kumon, and Koichi Monden
November 1973, Infection and immunity,
Toshiaki Shimizu, and Ko Yasumoto, and Yutaka Tatano, and Haruaki Tomioka, and Katsumasa Sato, and Chiaki Sano, and Hiromi Kumon, and Koichi Monden
November 2004, Memorias do Instituto Oswaldo Cruz,
Toshiaki Shimizu, and Ko Yasumoto, and Yutaka Tatano, and Haruaki Tomioka, and Katsumasa Sato, and Chiaki Sano, and Hiromi Kumon, and Koichi Monden
June 2011, Journal of clinical microbiology,
Toshiaki Shimizu, and Ko Yasumoto, and Yutaka Tatano, and Haruaki Tomioka, and Katsumasa Sato, and Chiaki Sano, and Hiromi Kumon, and Koichi Monden
August 2001, Electrophoresis,
Copied contents to your clipboard!